Redcare Pharmacy Aktie
154,40EUR | 4,70EUR | 3,14% |
WKN DE: A2AR94 / ISIN: NL0012044747
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 65,26 |
Galenica AG | 10,05 |
Michael Köhler | 7,23 |
American Funds Small Cap World Fund | 5,86 |
DWS Investment GmbH | 5,01 |
Capital Research & Management Co. (World Investors) | 5,01 |
Christoph Laubmann | 4,18 |
ETHENEA Independent Investors SA | 4,09 |
Robert Hess | 3,22 |
Frank Köhler | 3,08 |
Sylebra Capital Ltd. | 3,00 |
T Rowe Price International Discovery Fund | 2,90 |
Allianz Global Investors GmbH | 2,71 |
T. Rowe Price International Ltd. | 2,49 |
Government Pension Fund - Global (The) | 1,66 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 1 011 | 1 220 | 1 569 | 1 847 | 2 075 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,69 | 0,79 | 0,68 | 0,65 | 0,87 |
Bilanz (in Mio. EUR) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 211 | 254 | 433 | 344 | 500 |
Summe Anlagevermögen | 224 | 290 | 360 | 398 | 549 |
Summe Aktiva | 434 | 544 | 793 | 742 | 1 049 |
Bilanz (in Mio. EUR) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Gesamtverschuldung/ -verbindlichkeiten | 149 | 38 | 234 | 241 | 275 |
Summe Fremdkapital | 202 | 119 | 377 | 388 | 528 |
Summe Eigenkapital | 233 | 425 | 415 | 355 | 520 |
Summe Passiva | 434 | 544 | 793 | 742 | 1 049 |
Adresse
Erik de Rodeweg 11/13, 5975 WD Sevenum | |
Internet | http://www.redcare-pharmacy.com |
Management
Björn H. Söder
Chairman-Supervisory Board |
Carmen Herkenrath
Investor Relations Contact |
Dirk Brüse
Chief Commercial Officer |
Frank Köhler
Vice Chairman-Supervisory Board |
Henriette Peucker
Member-Supervisory Board |
Jaska Marianne de Bakker
Member-Supervisory Board |
Jasper Eenhorst
Chief Financial Officer |
Jérôme Cochet
Member-Supervisory Board |
Lode Fastré
Chief Information Officer |
Monica Ambrosi
Head-Investor Relations |
Olaf Heinrich
Chief Executive Officer |
Theresa Holler
Chief Operating Officer |